The Centers for Medicare & Medicaid Services (CMS) has said it will announce the next 15 drugs in scope for the second round ...

Meanwhile, the time has come to turn to our ever-growing to-do list. Sound familiar? So here are some items of interest. Have a great day, everyone. … Hims & Hers Health plans to sell compounded ...

The FDA okays AstraZeneca's Fasenra for treating adults with eosinophilic granulomatosis with polyangiitis. This is the ...

Japan’s MHLW accepts for review GSK’s NDA for Blenrep combinations in relapsed/refractory multiple myeloma: London, UK Wednesday, September 18, 2024, 10:00 Hrs [IST] GSK plc a ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

Medindia's A-Z index page eases your search for side effects of prescription and over-the-counter or OTC medications. Section deals with the comprehensive list of drugs approved by FDA.

More than 39 million people around the world could die from antibiotic-resistant infections over the next 25 years, according to a study published in The Lancet.  The new study by the Global Research ...

ScaleReadytm, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReadytm, today announced that ImmunoScape Pte. Ltd. (a Singapore-U.S. based TCR-T therapy company) has ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.